Increase in thalamic binding of [11C]PE2I in patients with schizophrenia: A positron emission tomography study of dopamine transporter

Journal of Psychiatric Research

Volumn 43, Issue 15, 2009, Pages 1219-1223

  Arakawa, Ryosuke ^a,b   Ichimiya, Tetsuya ^a,b   Ito, Hiroshi ^a   Takano, Akihiro ^a   Okumura, Masaki ^a,b   Takahashi, Hidehiko ^a   Takano, Harumasa ^a   Yasuno, Fumihiko ^a   Kato, Motoichiro ^c   Okubo, Yoshiro ^b   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

11C PE2I; Dopamine transporter; PANSS; Positron emission tomography; Schizophrenia; Thalamus

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DOPAMINE TRANSPORTER; PE2I C 11; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING AFFINITY; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ISOTOPE LABELING; MALE; PATHOPHYSIOLOGY; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PUTAMEN; SCHIZOPHRENIA; SUBSTANTIA NIGRA; SYMPTOM; THALAMUS;

ADULT; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTROPANES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; STATISTICS AS TOPIC; THALAMUS;

EID: 70349779416     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.04.009     Document Type: Article

References (29)

1. Buchsbaum M.S., Christian B.T., Lehrer D.S., Narayanan T.K., Shi B., Mantil J., et al. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophrenia Research 85 (2006) 232-244
2. Clinton S.M., and Meador-Woodruff J.H. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophrenia Research 69 (2004) 237-253
3. Clinton S.M., Ibrahim H.M., Frey K.A., Davis K.L., Haroutunian V., and Meador-Woodruff J.H. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin. The American Journal of Psychiatry 162 (2005) 1859-1871
4. Garcia-Cabezas M.A., Rico B., Sanchez-Gonzalez M.A., and Cavada C. Distribution of the dopamine innervation in the macaque and human thalamus. NeuroImage 34 (2007) 965-984
5. Green A.I. Schizophrenia and comorbid substance use disorder: effects of antipsychotics. The Journal of Clinical Psychiatry 66 Suppl. 6 (2005) 21-26
6. Hall H., Halldin C., Guilloteau D., Chalon S., Emond P., Besnard J., et al. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. NeuroImage 9 (1999) 108-116
7. Halldin C., Erixon-Lindroth N., Pauli S., Chou Y.H., Okubo Y., Karlsson P., et al. [11C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. European Journal of Nuclear Medicine and Molecular Imaging 30 (2003) 1220-1230
8. Hirvonen J., Johansson J., Teras M., Oikonen V., Lumme V., Virsu P., et al. Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility. Journal of Cerebral Blood Flow and Metabolism 28 (2008) 1059-1069
9. Hsiao M.C., Lin K.J., Liu C.Y., Tzen K.Y., and Yen T.C. Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1. Schizophrenia Research 65 (2003) 39-46
10. Ito H., Takahashi H., Arakawa R., Takano H., and Suhara T. Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography. NeuroImage 39 (2008) 555-565
11. Jucaite A., Odano I., Olsson H., Pauli S., Halldin C., and Farde L. Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study. European Journal of Nuclear Medicine and Molecular Imaging 33 (2006) 657-668
12. Laakso A., Vilkman H., Alakare B., Haaparanta M., Bergman J., Solin O., et al. Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. The American Journal of Psychiatry 157 (2000) 269-271
13. Laruelle M., Abi-Dargham A., van Dyck C., Gil R., D'Souza D.C., Krystal J., et al. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [123I]beta-CIT. Biological Psychiatry 47 (2000) 371-379
14. Lavalaye J., Linszen D.H., Booij J., Dingemans P.M., Reneman L., Habraken J.B., et al. Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT. Schizophrenia Research 47 (2001) 59-67
15. Mateos J.J., Lomena F., Parellada E., Mireia F., Fernandez-Egea E., Pavia J., et al. Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait. Psychopharmacology 191 (2007) 805-811
16. Melchitzky D.S., and Lewis D.A. Dopamine transporter-immunoreactive axons in the mediodorsal thalamic nucleus of the macaque monkey. Neuroscience 103 (2001) 1033-1042
17. Oke A.F., and Adams R.N. Elevated thalamic dopamine: possible link to sensory dysfunctions in schizophrenia. Schizophrenia Bulletin 13 (1987) 589-604
18. Praschak-Rieder N., Wilson A.A., Hussey D., Carella A., Wei C., Ginovart N., et al. Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biological Psychiatry 58 (2005) 825-830
19. Schlaepfer T.E., Pearlson G.D., Wong D.F., Marenco S., and Dannals R.F. PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects. The American Journal of Psychiatry 154 (1997) 1209-1213
20. Schmitt G.J., Meisenzahl E.M., Frodl T., La Fougere C., Hahn K., Moller H.J., et al. The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1. Journal of Psychopharmacology 19 (2005) 488-493
21. Schmitt G.J., Frodl T., Dresel S., la Fougere C., Bottlender R., Koutsouleris N., et al. Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience 256 (2006) 115-121
22. Schmitt G.J., la Fougere C., Dresel S., Frodl T., Hahn K., Moller H.J., et al. Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naive schizophrenic patients. Schizophrenia Research 101 (2008) 133-141
23. Takahashi H., Higuchi M., and Suhara T. The role of extrastriatal dopamine D2 receptors in schizophrenia. Biological Psychiatry 59 (2006) 919-928
24. Talbot P.S., Frankle W.G., Hwang D.R., Huang Y., Suckow R.F., Slifstein M., et al. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans. Synapse 55 (2005) 164-175
25. Talvik M., Nordstrom A.L., Olsson H., Halldin C., and Farde L. Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457. The International Journal of Neuropsychopharmacology 6 (2003) 361-370
26. Talvik M., Nordstrom A.L., Okubo Y., Olsson H., Borg J., Halldin C., et al. Dopamine D2 receptor binding in drug-naive patients with schizophrenia examined with raclopride-C11 and positron emission tomography. Psychiatry Research 148 (2006) 165-173
27. Wilson A.A., Ginovart N., Schmidt M., Meyer J.H., Threlkeld P.G., and Houle S. Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of 11C-labeled 2-(phenylthio)araalkylamines. Journal of Medicinal Chemistry 43 (2000) 3103-3110
28. Yang Y.K., Yu L., Yeh T.L., Chiu N.T., Chen P.S., and Lee I.H. Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. The American Journal of Psychiatry 161 (2004) 1496-1498
29. Yasuno F., Suhara T., Okubo Y., Sudo Y., Inoue M., Ichimiya T., et al. Low dopamine d2 receptor binding in subregions of the thalamus in schizophrenia. The American Journal of Psychiatry 161 (2004) 1016-1022